[2019-nCoV: new challenges from coronavirus].
Identifieur interne : 000814 ( PubMed/Curation ); précédent : 000813; suivant : 000815[2019-nCoV: new challenges from coronavirus].
Auteurs : H Y Tian [République populaire de Chine]Source :
- Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] [ 0253-9624 ] ; 2020.
Abstract
The outbreak of pneumonia caused by the novel coronavirus 2019-nCoV in Wuhan, Hubei province of China, at the end of 2019 shaped tremendous challenges to China's public health and clinical treatment. The virus belongs to the β genus Coronavirus in the family Corornaviridae, and is closely related to SARS-CoV and MERS-CoV, causing severe symptoms of pneumonia. The virus is transmitted through droplets, close contact, and other means, and patients in the incubation period could potentially transmit the virus to other persons. According to current observations, 2019-nCoV is weaker than SARS in pathogenesis, but has stronger transmission competence; it's mechanism of cross-species spread might be related with angiotensin-converting enzyme Ⅱ (ACE2), which is consistent with the receptor SARS-CoV. After the outbreak of this disease, Chinese scientists invested a lot of energy to carry out research by developing rapid diagnostic reagents, identifying the characters of the pathogen, screening out clinical drugs that may inhibit the virus, and are rapidly developing vaccines. The emergence of 2019-nCoV reminds us once again of the importance of establishing a systematic coronavirus surveillance network. It also poses new challenges to prevention and control of the emerging epidemic and rapidly responses on scientific research.
DOI: 10.3760/cma.j.issn.0253-9624.2020.0001
PubMed: 32023682
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000814
Links to Exploration step
pubmed:32023682Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[2019-nCoV: new challenges from coronavirus].</title><author><name sortKey="Tian, H Y" sort="Tian, H Y" uniqKey="Tian H" first="H Y" last="Tian">H Y Tian</name><affiliation wicri:level="1"><nlm:affiliation>State Key Laboratory of Remote Sensing Science/College of Global Change and Earth System Science/Beijing Normal University, Beijing 100875, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>State Key Laboratory of Remote Sensing Science/College of Global Change and Earth System Science/Beijing Normal University, Beijing 100875</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32023682</idno><idno type="pmid">32023682</idno><idno type="doi">10.3760/cma.j.issn.0253-9624.2020.0001</idno><idno type="wicri:Area/PubMed/Corpus">000814</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000814</idno><idno type="wicri:Area/PubMed/Curation">000814</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000814</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[2019-nCoV: new challenges from coronavirus].</title><author><name sortKey="Tian, H Y" sort="Tian, H Y" uniqKey="Tian H" first="H Y" last="Tian">H Y Tian</name><affiliation wicri:level="1"><nlm:affiliation>State Key Laboratory of Remote Sensing Science/College of Global Change and Earth System Science/Beijing Normal University, Beijing 100875, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>State Key Laboratory of Remote Sensing Science/College of Global Change and Earth System Science/Beijing Normal University, Beijing 100875</wicri:regionArea></affiliation></author></analytic><series><title level="j">Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]</title><idno type="ISSN">0253-9624</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The outbreak of pneumonia caused by the novel coronavirus 2019-nCoV in Wuhan, Hubei province of China, at the end of 2019 shaped tremendous challenges to China's public health and clinical treatment. The virus belongs to the β genus Coronavirus in the family Corornaviridae, and is closely related to SARS-CoV and MERS-CoV, causing severe symptoms of pneumonia. The virus is transmitted through droplets, close contact, and other means, and patients in the incubation period could potentially transmit the virus to other persons. According to current observations, 2019-nCoV is weaker than SARS in pathogenesis, but has stronger transmission competence; it's mechanism of cross-species spread might be related with angiotensin-converting enzyme Ⅱ (ACE2), which is consistent with the receptor SARS-CoV. After the outbreak of this disease, Chinese scientists invested a lot of energy to carry out research by developing rapid diagnostic reagents, identifying the characters of the pathogen, screening out clinical drugs that may inhibit the virus, and are rapidly developing vaccines. The emergence of 2019-nCoV reminds us once again of the importance of establishing a systematic coronavirus surveillance network. It also poses new challenges to prevention and control of the emerging epidemic and rapidly responses on scientific research.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32023682</PMID><DateRevised><Year>2020</Year><Month>02</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0253-9624</ISSN><JournalIssue CitedMedium="Print"><Volume>54</Volume><Issue>0</Issue><PubDate><Year>2020</Year><Month>Feb</Month><Day>03</Day></PubDate></JournalIssue><Title>Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]</Title><ISOAbbreviation>Zhonghua Yu Fang Yi Xue Za Zhi</ISOAbbreviation></Journal><ArticleTitle>[2019-nCoV: new challenges from coronavirus].</ArticleTitle><Pagination><MedlinePgn>E001</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.issn.0253-9624.2020.0001</ELocationID><Abstract><AbstractText>The outbreak of pneumonia caused by the novel coronavirus 2019-nCoV in Wuhan, Hubei province of China, at the end of 2019 shaped tremendous challenges to China's public health and clinical treatment. The virus belongs to the β genus Coronavirus in the family Corornaviridae, and is closely related to SARS-CoV and MERS-CoV, causing severe symptoms of pneumonia. The virus is transmitted through droplets, close contact, and other means, and patients in the incubation period could potentially transmit the virus to other persons. According to current observations, 2019-nCoV is weaker than SARS in pathogenesis, but has stronger transmission competence; it's mechanism of cross-species spread might be related with angiotensin-converting enzyme Ⅱ (ACE2), which is consistent with the receptor SARS-CoV. After the outbreak of this disease, Chinese scientists invested a lot of energy to carry out research by developing rapid diagnostic reagents, identifying the characters of the pathogen, screening out clinical drugs that may inhibit the virus, and are rapidly developing vaccines. The emergence of 2019-nCoV reminds us once again of the importance of establishing a systematic coronavirus surveillance network. It also poses new challenges to prevention and control of the emerging epidemic and rapidly responses on scientific research.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>H Y</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Remote Sensing Science/College of Global Change and Earth System Science/Beijing Normal University, Beijing 100875, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>chi</Language><GrantList CompleteYN="Y"><Grant><GrantID>2018QNRC001</GrantID><Agency>Young Elite Scientist Sponsorship Program by CAST</Agency><Country></Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhonghua Yu Fang Yi Xue Za Zhi</MedlineTA><NlmUniqueID>7904962</NlmUniqueID><ISSNLinking>0253-9624</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><OtherAbstract Type="Publisher" Language="chi"><AbstractText>2019年岁末，在武汉暴发新型冠状病毒（2019-nCoV）引起的肺炎流行，给我国公共卫生和临床救治带来巨大挑战。2019-nCoV属于冠状病毒科β冠状病毒属，与严重急性呼吸综合征相关冠状病毒（SARS-CoV）和中东呼吸综合征相关冠状病毒（MERS-CoV）近缘，都会导致严重肺炎症状。该病毒经飞沫、接触等途径传播，潜伏期患者即具备传播性。目前数据表明：2019-nCoV比SARS-CoV毒力弱，但传播力强；造成其能够跨种传播的受体可能与SARS-CoV一致，都是血管紧张素转化酶Ⅱ（ACE2）。在此疾病暴发后，我国科技人员投入大量精力开展研究，快速开发出诊断试剂，初步确定了病原特性，并已筛选出可能抑制该病毒的临床药物，也正在加快研发疫苗。2019-nCoV的出现再次提醒我们建立系统的冠状病毒监测网络的重要性；也给突发疫情防控和应急科研提出了新挑战。.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">2019-nCoV</Keyword><Keyword MajorTopicYN="N">Coronavirus</Keyword><Keyword MajorTopicYN="N">Public health</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32023682</ArticleId><ArticleId IdType="doi">10.3760/cma.j.issn.0253-9624.2020.0001</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000814 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000814 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:32023682
|texte= [2019-nCoV: new challenges from coronavirus].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:32023682" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |